
Hikal’s Market Assessment Revised Amidst Challenging Financial Trends
2025-12-04 11:08:06Hikal, a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently undergone a revision in its market evaluation metrics. This shift reflects a reassessment of the company’s financial health, valuation, and technical outlook amid ongoing operational challenges and market performance trends.
Read More
Hikal Sees Exceptional Trading Volume Amid Rising Investor Interest
2025-12-04 10:00:10Hikal Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has emerged as one of the most actively traded stocks recently, with a remarkable surge in trading volume and investor participation. The stock's performance has outpaced its sector peers, reflecting heightened market attention and liquidity.
Read More
Hikal Ltd Sees Elevated Trading Activity Amidst Sector Outperformance
2025-12-04 10:00:08Hikal Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has emerged as one of the most actively traded stocks by value on 4 December 2025. The stock demonstrated notable trading volumes and value turnover, alongside a performance that outpaced its sector peers, reflecting heightened investor interest and liquidity in the market.
Read MoreIs Hikal technically bullish or bearish?
2025-12-04 08:19:25Overview of Current Technical Trends As of 3 December 2025, Hikal’s technical trend has transitioned from a clear bearish stance to a mildly bearish one. This subtle shift indicates that while downward pressure remains, the intensity of the decline has somewhat eased. The stock’s current price stands at ₹243.75, having opened the day with a low of ₹227.40 and reaching a high of ₹254.60, reflecting intraday volatility within a relatively narrow range. Examining the 52-week range, Hikal’s shares have traded between ₹217.35 and ₹464.50, highlighting significant depreciation from its peak over the past year. This wide range underscores the challenges the stock has faced amid broader market conditions and sector-specific headwinds. Mixed Signals from Key Tech...
Read More
Hikal Stock Analysis: Technical Momentum Shifts Amid Mixed Indicators
2025-12-04 08:00:56Hikal, a key player in the Pharmaceuticals & Biotechnology sector, has experienced notable shifts in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Recent price movements and indicator assessments reveal a nuanced market stance as the stock navigates volatility and investor sentiment.
Read MoreWhy is Hikal falling/rising?
2025-12-04 00:40:33Short-Term Price Movement and Market Activity Hikal’s stock outperformed its sector by 13.02% on the day, trading within a wide range of ₹27.2, signalling heightened volatility and investor interest. The stock’s price currently sits above its 5-day, 20-day, and 50-day moving averages, suggesting short-term bullish momentum. However, it remains below the 100-day and 200-day moving averages, indicating that longer-term trends have yet to turn decisively positive. Investor participation has notably increased, with delivery volumes on 02 Dec rising by 24.99% compared to the five-day average, reaching 83.52 lakh shares. This uptick in trading activity points to renewed buying interest, possibly driven by bargain hunting or speculative positioning amid the stock’s recent und...
Read More
Hikal Sees Exceptional Trading Volume Amidst Wide Price Range on 3 Dec 2025
2025-12-03 14:00:06Hikal Ltd, a key player in the Pharmaceuticals & Biotechnology sector, recorded one of the highest trading volumes on 3 December 2025, with over 2.48 crore shares exchanging hands. The stock exhibited a notable intraday price range, reflecting heightened market activity and investor interest amid a volatile trading session.
Read More
Hikal Ltd Sees Significant Trading Activity Amidst Sector Underperformance
2025-12-03 13:00:09Hikal Ltd, a notable player in the Pharmaceuticals & Biotechnology sector, recorded one of the highest value turnovers on 3 December 2025, with trading volumes and price movements that outpaced both its sector and the broader market indices. The stock’s performance on this day highlights a marked divergence from the sector’s subdued returns, reflecting heightened investor interest and liquidity in this small-cap company.
Read More
Hikal Hits Intraday High with Strong 7.96% Surge Amid Mixed Market Trends
2025-12-03 09:32:18Hikal recorded a robust intraday performance on 3 December 2025, touching a day’s high of Rs 242.65, reflecting a 7.96% gain. This surge notably outpaced the Pharmaceuticals & Biotechnology sector and contrasted with the broader market’s subdued movement.
Read MoreCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
07-Jan-2026 | Source : BSECompliance Certificate Under Regulation 74 (5) of SEBI (DP) Regulations 2018
Closure of Trading Window
29-Dec-2025 | Source : BSEClosure of Trading Window
Disclosure Under Regulation 30 Of SEBI Listing Regulations
26-Dec-2025 | Source : BSEDisclosure Under Regulation 30 of SEBI Listing Regulations
Corporate Actions
No Upcoming Board Meetings
Hikal Ltd has declared 40% dividend, ex-date: 02 Sep 25
Hikal Ltd has announced 2:10 stock split, ex-date: 27 Feb 15
Hikal Ltd has announced 1:2 bonus issue, ex-date: 22 Jun 18
No Rights history available